SCHEMBL19913231

SCHEMBL19913231

Cc1cccc(-c2ccc3c4ccccc4n(-c4cc(-c5cc(C)nc(C)c5)c(-n5c6ccccc6c6ccc(-c7cccc(C)c7)cc65)cc4C#N)c3c2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.36
HIF1A Q16665 1/20 0.36
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
IMPDH2 P12268 1/20 0.35
LRRK2 Q5S007 2/20 0.35
KDM4A O75164 1/20 0.35
KDM5B Q9UGL1 1/20 0.35
KDM4E B2RXH2 3/20 0.34
ALDH1A1 P00352 2/20 0.34
GLA P06280 2/20 0.34
HPGD P15428 2/20 0.34
S1PR4 O95977 1/20 0.34
GAA P10253 1/20 0.34
S1PR1 P21453 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19913239 0.97 AR (0.40) ARSMN1; SMN2HIF1AADORA2AADORA1
SCHEMBL19913242 0.93 GRIN1 (0.33) SMN1; SMN2HIF1AIMPDH2KDM5BKDM4E
SCHEMBL19909528 0.93 CYP1A2 (0.38) SMN1; SMN2HIF1AKDM4EALDH1A1GLA
SCHEMBL19913237 0.92 MAOA (0.34) ARSMN1; SMN2HIF1AADORA2AADORA1
SCHEMBL23487765 0.91 AR (0.37) ARADORA2AADORA1IMPDH2LRRK2
SCHEMBL19919714 0.91 ADORA2A (0.37) SMN1; SMN2HIF1AADORA2AALDH1A1CYP1A2
SCHEMBL19913217 0.90 KDM4E (0.36) SMN1; SMN2IMPDH2KDM4EALDH1A1GLA
SCHEMBL22170397 0.90 KDM4E (0.36) SMN1; SMN2IMPDH2KDM4EALDH1A1GLA
SCHEMBL19909514 0.90 CYP1A2 (0.40) SMN1; SMN2HIF1AKDM4EALDH1A1GLA
SCHEMBL19919557 0.89 AR (0.41) ARSMN1; SMN2HIF1AADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-10665792-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2020-05-26 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 AR 4245/4885SMN1; SMN2 4471/4885HIF1A 4318/4885
US-10665792-B2 Organic molecules for use in optoelectronic devices OR10J3, CFD, AOX1 AR 4444/4885SMN1; SMN2 4607/4885HIF1A 2764/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 AR 4245/4885SMN1; SMN2 4471/4885HIF1A 4318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.